Drug: VINCRISTINE SULFATE. Injury: Second primary malignancy Quarter: 2016Q3
Total Records: 5 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
123990772 | VINCRISTINE SULFATE. | Second primary malignancy | PFIZER | 7.00 YR | M | 0 | 20160713 | FR |
125285231 | VINCRISTINE SULFATE. | Second primary malignancy | PFIZER | 33.00 YR | F | 0 | 20160705 | CA |
126734974 | VINCRISTINE SULFATE. | Second primary malignancy | PFIZER | 8.00 YR | M | 0 | 20160920 | US |
127206021 | VINCRISTINE SULFATE. | Second primary malignancy | PFIZER | 56.00 YR | F | 0 | 20160907 | US |
127809601 | VINCRISTINE SULFATE. | Second primary malignancy | PFIZER | 23.00 YR | M | 0 | 20160926 | US |
Total Records: 5 Number of Pages: 1